Michael Fanucchi

2.0k total citations · 1 hit paper
33 papers, 1.5k citations indexed

About

Michael Fanucchi is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Michael Fanucchi has authored 33 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Oncology, 13 papers in Pulmonary and Respiratory Medicine and 7 papers in Molecular Biology. Recurrent topics in Michael Fanucchi's work include Cancer Immunotherapy and Biomarkers (6 papers), Lung Cancer Treatments and Mutations (5 papers) and Biochemical and Molecular Research (4 papers). Michael Fanucchi is often cited by papers focused on Cancer Immunotherapy and Biomarkers (6 papers), Lung Cancer Treatments and Mutations (5 papers) and Biochemical and Molecular Research (4 papers). Michael Fanucchi collaborates with scholars based in United States, France and Spain. Michael Fanucchi's co-authors include Brian L. Samuels, David C. Harmon, Dennis A. Priebat, Scott H. Okuno, J. Kyle Wathen, Peter F. Thall, Denise K. Reinke, Robert G. Maki, Shreyaskumar Patel and Scott M. Schuetze and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Cancer.

In The Last Decade

Michael Fanucchi

33 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Randomized Phase II Study of Gemcitabine and Docetaxel Compared With Gemcitabine Alone in Patients With Metastatic Soft Tissue Sarcomas: Results of Sarcoma Alliance for Research Through Collaboration Study 002

2007 531 citations Robert G. Maki, J. Kyle Wathen et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael Fanucchi United States	15	809	764	332	253	248	33	1.5k
Akiko Ono Japan	19	673 0.8×	585 0.8×	299 0.9×	133 0.5×	224 0.9×	54	1.6k
M. Clerici Italy	15	1.2k 1.5×	1.4k 1.8×	495 1.5×	225 0.9×	63 0.3×	33	2.1k
Süleyman Buyukberber Türkiye	21	473 0.6×	653 0.9×	256 0.8×	102 0.4×	92 0.4×	136	1.5k
István Molnár United States	18	277 0.3×	566 0.7×	464 1.4×	80 0.3×	188 0.8×	45	2.1k
Marija Bojić Austria	10	350 0.4×	364 0.5×	283 0.9×	353 1.4×	98 0.4×	39	948
Νicolas Tsavaris Greece	22	495 0.6×	999 1.3×	259 0.8×	230 0.9×	43 0.2×	87	1.7k
Yuichiro Takeda Japan	20	629 0.8×	780 1.0×	387 1.2×	145 0.6×	43 0.2×	123	1.6k
Abdurrahman Işıkdoğan Türkiye	19	424 0.5×	537 0.7×	204 0.6×	82 0.3×	75 0.3×	146	1.2k
Dusan Kotasek Australia	28	542 0.7×	1.2k 1.5×	448 1.3×	113 0.4×	577 2.3×	104	2.3k
Anna Fedeli Italy	17	369 0.5×	536 0.7×	108 0.3×	73 0.3×	207 0.8×	43	939

Countries citing papers authored by Michael Fanucchi

Since Specialization

Citations

This map shows the geographic impact of Michael Fanucchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Fanucchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Fanucchi more than expected).

Fields of papers citing papers by Michael Fanucchi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Fanucchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Fanucchi. The network helps show where Michael Fanucchi may publish in the future.

Co-authorship network of co-authors of Michael Fanucchi

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Fanucchi. A scholar is included among the top collaborators of Michael Fanucchi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Fanucchi. Michael Fanucchi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Huang, Weihua, Changhong Yin, Yee Him Cheung, et al.. (2020). Blood-based gene expression profiling to reveal potential response biomarkers for immunotherapy in advanced lung cancer.. Journal of Clinical Oncology. 38(15_suppl). e15155–e15155. 2 indexed citations

Fanucchi, Michael, et al.. (2019). Paraneoplastic syndromes in lung cancer and their management. Annals of Translational Medicine. 7(15). 359–359. 13 indexed citations

Cheung, Yee Him, Weihua Huang, Changhong Yin, et al.. (2019). Gene expression profiles of peripheral blood mononuclear cells from patients with advanced non-small cell lung cancer treated with anti-PD-1 monoclonal antibodies.. Journal of Clinical Oncology. 37(15_suppl). e14107–e14107. 1 indexed citations

Parikh, Kaushal, Jibran Ahmed, Carmelo Puccio, et al.. (2018). Peripheral monocytes and neutrophils predict response to immune checkpoint inhibitors in patients with metastatic non-small cell lung cancer. Cancer Immunology Immunotherapy. 67(9). 1365–1370. 27 indexed citations

Parikh, Kaushal, Jibran Ahmed, Carmelo Puccio, et al.. (2018). Monocytes and neutrophils as a predictive marker of response to immune checkpoint inhibitors (ICI) in metastatic non-small cell lung cancer (mNSCLC).. Journal of Clinical Oncology. 36(15_suppl). e21165–e21165. 1 indexed citations

Zhong, Minghao, et al.. (2017). Identification of distinctive patterns in cell signaling pathways in glioblastoma multiforme subtypes using gene expression TCGA data sets.. Journal of Clinical Oncology. 35(15_suppl). e23162–e23162. 1 indexed citations

Katzel, Jed Abraham, Michael Fanucchi, & Zujun Li. (2009). Recent advances of novel targeted therapy in non-small cell lung cancer. Journal of Hematology & Oncology. 2(1). 2–2. 55 indexed citations

Maki, Robert G., J. Kyle Wathen, Shreyaskumar Patel, et al.. (2007). Randomized Phase II Study of Gemcitabine and Docetaxel Compared With Gemcitabine Alone in Patients With Metastatic Soft Tissue Sarcomas: Results of Sarcoma Alliance for Research Through Collaboration Study 002. Journal of Clinical Oncology. 25(19). 2755–2763. 531 indexed citations breakdown →

Fanucchi, Michael & Fadlo R. Khuri. (2006). Taxanes in the Treatment of Non-Small Cell Lung Cancer. PubMed. 5(3). 181–191. 4 indexed citations

10.

Guiteau, Jacfranz J., et al.. (2006). Hypoglycemia in the Setting of Advanced Gastrointestinal Stromal Tumor. The American Surgeon. 72(12). 1225–1230. 23 indexed citations

11.

Fanucchi, Michael. (2004). Update on the management of connective tissue malignancies. Seminars in Oncology. 31(2 Suppl 4). 16–19. 3 indexed citations

12.

Fanucchi, Michael & Fadlo R. Khuri. (2004). Chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck. Seminars in Oncology. 31(6). 809–815. 30 indexed citations

13.

Richards, Sarah, et al.. (2003). Selective Serotonin Reuptake Inhibitor-induced Rhabdomyolysis Associated with Irinotecan. Southern Medical Journal. 96(10). 1031–1033. 19 indexed citations

14.

Fanucchi, Michael, et al.. (2001). Clear Cell Carcinoma of the Ovary. American Journal of Clinical Oncology. 24(1). 99–100. 4 indexed citations

15.

Fanucchi, Michael, John A. Glaspy, Jeffrey Crawford, et al.. (1997). Effects of Polyethylene Glycol–Conjugated Recombinant Human Megakaryocyte Growth and Development Factor on Platelet Counts after Chemotherapy for Lung Cancer. New England Journal of Medicine. 336(6). 404–409. 210 indexed citations

16.

Kris, Mark G., et al.. (1989). Phase II Trial of Trimetrexate in Patients with Stage III and IV Non-Small-Cell Lung Cancer. American Journal of Clinical Oncology. 12(1). 24–26. 18 indexed citations

17.

Fanucchi, Michael, et al.. (1988). Antagonistic interactions of hexamethylene bisacetamide in combination with 1-β-d-arabinofuranosylcytosine, adriamycin and harringtonine on the growth and differentiation of HL-60 cells in vitro. Leukemia Research. 12(10). 853–859. 3 indexed citations

18.

Scheck, Adrienne C., Richard W. Price, Pedro Marques‐Vidal, et al.. (1988). Incorporation and metabolism of 2′-fluoro-5-substituted arabinosyl pyrimidines and their selective inhibition of viral DNA synthesis in herpes simplex virus type 1 (HSV-1)-infected and mock-infected Vero cells. Antiviral Research. 10(4-5). 153–166. 16 indexed citations

19.

Fanucchi, Michael, et al.. (1987). Cell differentiation effects of 2′-fluoro-1-β-d-arabinofuranosyl pyrimidines in HL-60 cells. Leukemia Research. 11(11). 1031–1039. 3 indexed citations

20.

Fanucchi, Michael, Kyoichi A. Watanabe, Jack J. Fox, & Ting‐Chao Chou. (1986). Kinetics and substrate specificity of human and canine cytidine deaminase. Biochemical Pharmacology. 35(7). 1199–1201. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact